Doctor Anywhere (DA), a regional tech-led healthcare company headquartered in Singapore, has raised its Series C financing round, led by growth equity investor Asia Partners. The round also attracted other investors including Novo Holdings, Philips and OSK-SBI Venture Partners.

At $88 million SGD ($65.7 million), it is one of the largest private funding rounds ever raised by a healthtech company in Southeast Asia.

Existing investors also participated in the round, including Singapore-based global investor EDBI, Square Peg, IHH Healthcare, Kamet Capital and Pavilion Capital. This round brings the total capital raised by Doctor Anywhere since founding to more than S$140 million.

As a result of the financing, Oliver Rippel, Co-Founder and Partner of Asia Partners, and Dr Amit Kakar, Senior Partner, Head of Novo Holdings Equity Asia will come onboard DA's Board of Directors.

This latest investment will significantly bolster DA's market leadership and put the group in a leading position to further deepen its presence in its existing markets. It will also allow the group to expand into new markets, to drive its mission of transforming the regional healthcare landscape through technology.

Doctor Anywhere is currently available in Singapore, Malaysia, Thailand, Vietnam, and the Philippines. The group also recently announced the establishment of regional tech hubs in Bangalore, India, and Ho Chi Minh City, Vietnam.